Biohaven Pharma (BHVN) Misses Q4 EPS by 22c, Revenue Beats
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NYSE: BHVN) | Delayed: 15.16 -0.26 (1.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.42 | 52 Week High | $ | |||
| Open | $15.98 | 52 Week Low | $ | |||
| Day High | $16.11 | P/E | N/A | |||
| Day Low | $15.08 | EPS | $ | |||
| Volume | 2,592,271 | |||||
